AI assistant
Pacira BioSciences, Inc. — Director's Dealing 2012
Mar 29, 2012
32125_dirs_2012-03-29_16ac1f77-ba63-4803-925f-c758fe5be6f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-03-21
Reporting Person: Markvicka Taunia (Vice President, Commercial)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.61 | 2020-09-01 | Common Stock (21385) | Direct | |
| Employee Stock Option (right to buy) | $1.61 | 2020-09-01 | Common Stock (29754) | Direct | |
| Employee Stock Option (right to buy) | $5.49 | 2020-12-28 | Common Stock (18349) | Direct |
Footnotes
F1: The stock option vests as follows: 25% of the shares shall vest on the one-year anniversary of the Vesting Commencement Date of September 2, 2010; 1/36th of the shares shall vest over the three year period thereafter.
F2: The stock option vests as follows: 50% of the shares are vested upon the date of grant; 50% of the remaining shares shall vest in monthly installments over the next 24 months.
F3: The stock option vests as follows: 25% of the shares shall vest on the one-year anniversary of the Vesting Commencement Date of December 29, 2010; 1/36th of the shares shall vest over the three year period thereafter.